Abstract

Multi-locus sequencing typing (MLST) is widely used to monitor the phylogeny of microbial outbreaks. However, several strains of vancomycin-resistant Enterococcus faecium (VREfm) with a missing MLST locus (pstS) have recently emerged in Australia, with a few cases also reported in England. Here, we identified similarly distinct strains circulating in two neighbouring hospitals in Scotland. Whole genome sequencing of five VREfm strains isolated from these hospitals identified four pstS-null strains in both hospitals, while the fifth was multi-locus sequence type (ST) 262, which is the first documented in the UK. All five Scottish isolates had an insertion in the tetM gene, which is associated with increased susceptibility to tetracyclines, providing no other tetracycline-resistant gene is present. Such an insertion, which encompasses a dfrG gene and two currently uncharacterised genes, was additionally identified in all tested vanA-type pstS-null VREfm strains (5 English and 68 Australian). Phylogenetic comparison with other VREfm genomes indicates that the four pstS-null Scottish isolates sequenced in this study are more closely related to pstS-null strains from Australia rather than the English pstS-null isolates. Given how rapidly such pstS-null strains have expanded in Australia, the emergence of this clone in Scotland raises concerns for a potential outbreak.

Highlights

  • Vancomycin-resistant Enterococcus spp. (VRE) was first identified about three decades ago and has become a major nosocomial pathogen

  • Multi-locus sequencing typing (MLST) analysis is inferior to whole genome sequence analysis for outbreak investigations of vancomycin-resistant Enterococcus faecium (VREfm) [7], due to the high rate of recombination events occurring within the E. faecium chromosome that cannot be captured adequately by MLST analysis [27,28]

  • The emergence of non-typeable VREfm strains poses an extra obstacle in implementing the MLST scheme for VREfm phylogenetic analysis

Read more

Summary

Introduction

Vancomycin-resistant Enterococcus spp. (VRE) was first identified about three decades ago and has become a major nosocomial pathogen. (VRE) was first identified about three decades ago and has become a major nosocomial pathogen. It typically infects immunocompromised patients and can cause endocarditis, bloodstream, urinary tract, and skin and skin structure infections [1]. VRE infections are generally more serious than those caused by vancomycinsusceptible enterococci, and are associated with higher mortality rates [2]. Emergence of an Australian-like pstS-null VREfm clone in Scotland and analysis, decision to publish, or preparation of the manuscript

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call